231 related articles for article (PubMed ID: 18329664)
1. In vitro neutralization of equid herpesvirus 1 mediated by recombinant antibodies.
Molinková D; Skládal P; Celer V
J Immunol Methods; 2008 Apr; 333(1-2):186-91. PubMed ID: 18329664
[TBL] [Abstract][Full Text] [Related]
2. Serum antibody responses to equine herpesvirus 1 glycoprotein D in horses, pregnant mares and young foals.
Foote CE; Love DN; Gilkerson JR; Rota J; Trevor-Jones P; Ruitenberg KM; Wellington JE; Whalley JM
Vet Immunol Immunopathol; 2005 May; 105(1-2):47-57. PubMed ID: 15797474
[TBL] [Abstract][Full Text] [Related]
3. Equine herpesvirus 1 glycoprotein D expressed in E. coli provides partial protection against equine herpesvirus infection in mice and elicits virus-neutralizing antibodies in the horse.
Weerasinghe CU; Learmonth GS; Gilkerson JR; Foote CE; Wellington JE; Whalley JM
Vet Immunol Immunopathol; 2006 May; 111(1-2):59-66. PubMed ID: 16473414
[TBL] [Abstract][Full Text] [Related]
4. Inoculation of mares and very young foals with EHV-1 glycoproteins D and B reduces virus shedding following respiratory challenge with EHV-1.
Foote CE; Raidal SL; Pecenpetelovska G; Wellington JE; Whalley JM
Vet Immunol Immunopathol; 2006 May; 111(1-2):97-108. PubMed ID: 16504306
[TBL] [Abstract][Full Text] [Related]
5. Antibody and cellular immune responses following DNA vaccination and EHV-1 infection of ponies.
Soboll G; Hussey SB; Whalley JM; Allen GP; Koen MT; Santucci N; Fraser DG; Macklin MD; Swain WF; Lunn DP
Vet Immunol Immunopathol; 2006 May; 111(1-2):81-95. PubMed ID: 16549215
[TBL] [Abstract][Full Text] [Related]
6. Pathogenic potential of equine alphaherpesviruses: the importance of the mononuclear cell compartment in disease outcome.
Osterrieder N; Van de Walle GR
Vet Microbiol; 2010 Jun; 143(1):21-8. PubMed ID: 20202764
[TBL] [Abstract][Full Text] [Related]
7. Isolation and characterization of neutralizing single-chain antibodies against Xenopus mitogen-activated protein kinase kinase from phage display libraries.
Kosako H; Akamatsu Y; Tsurushita N; Lee KK; Gotoh Y; Nishida E
Biochemistry; 1996 Oct; 35(40):13212-21. PubMed ID: 8855960
[TBL] [Abstract][Full Text] [Related]
8. Live-attenuated recombinant equine herpesvirus type 1 (EHV-1) induces a neutralizing antibody response against West Nile virus (WNV).
Rosas CT; Tischer BK; Perkins GA; Wagner B; Goodman LB; Osterrieder N
Virus Res; 2007 Apr; 125(1):69-78. PubMed ID: 17241683
[TBL] [Abstract][Full Text] [Related]
9. Use of DNA and recombinant canarypox viral (ALVAC) vectors for equine herpes virus vaccination.
Minke JM; Fischer L; Baudu P; Guigal PM; Sindle T; Mumford JA; Audonnet JC
Vet Immunol Immunopathol; 2006 May; 111(1-2):47-57. PubMed ID: 16580075
[TBL] [Abstract][Full Text] [Related]
10. One way protection between equid herpesvirus 1 and 4 in vivo.
Edington N; Bridges CG
Res Vet Sci; 1990 Mar; 48(2):235-9. PubMed ID: 2159176
[TBL] [Abstract][Full Text] [Related]
11. Immune escape of equine herpesvirus 1 and other herpesviruses of veterinary importance.
van der Meulen KM; Favoreel HW; Pensaert MB; Nauwynck HJ
Vet Immunol Immunopathol; 2006 May; 111(1-2):31-40. PubMed ID: 16472872
[TBL] [Abstract][Full Text] [Related]
12. Utilisation of bacteriophage display libraries to identify peptide sequences recognised by equine herpesvirus type 1 specific equine sera.
Birch-Machin I; Ryder S; Taylor L; Iniguez P; Marault M; Ceglie L; Zientara S; Cruciere C; Cancellotti F; Koptopoulos G; Mumford J; Binns M; Davis-Poynter N; Hannant D
J Virol Methods; 2000 Jul; 88(1):89-104. PubMed ID: 10921846
[TBL] [Abstract][Full Text] [Related]
13. Recombinant single chain Fv antibodies specific for glycoprotein D of equid herpesvirus 1.
Molinková D; Celer V
Folia Microbiol (Praha); 2006; 51(5):492-6. PubMed ID: 17176773
[TBL] [Abstract][Full Text] [Related]
14. Absence of viral envelope proteins in equine herpesvirus 1-infected blood mononuclear cells during cell-associated viremia.
van der Meulen K; Caij B; Pensaert M; Nauwynck H
Vet Microbiol; 2006 Mar; 113(3-4):265-73. PubMed ID: 16387454
[TBL] [Abstract][Full Text] [Related]
15. The C-terminal regions of the envelope glycoprotein gp2 of equine herpesviruses 1 and 4 are antigenically distinct.
Learmonth GS; Love DN; Wellington JE; Gilkerson JR; Whalley JM
Arch Virol; 2002 Mar; 147(3):607-15. PubMed ID: 11958459
[TBL] [Abstract][Full Text] [Related]
16. Immune responses to commercial equine vaccines against equine herpesvirus-1, equine influenza virus, eastern equine encephalomyelitis, and tetanus.
Holmes MA; Townsend HG; Kohler AK; Hussey S; Breathnach C; Barnett C; Holland R; Lunn DP
Vet Immunol Immunopathol; 2006 May; 111(1-2):67-80. PubMed ID: 16476488
[TBL] [Abstract][Full Text] [Related]
17. Equine herpesvirus 1 (EHV-1) glycoprotein D DNA inoculation in horses with pre-existing EHV-1/EHV-4 antibody.
Ruitenberg KM; Love DN; Gilkerson JR; Wellington JE; Whalley JM
Vet Microbiol; 2000 Sep; 76(2):117-27. PubMed ID: 10946142
[TBL] [Abstract][Full Text] [Related]
18. Identification of another B-cell epitope in the type-specific region of equine herpesvirus 4 glycoprotein G.
Maeda K; Mizukoshi F; Hamano M; Kai K; Kondo T; Matsumura T
Clin Diagn Lab Immunol; 2005 Jan; 12(1):122-4. PubMed ID: 15642995
[TBL] [Abstract][Full Text] [Related]
19. Anti-estradiol-17beta single-chain Fv fragments: Generation, characterization, gene randomization, and optimized phage display.
Kobayashi N; Kato Y; Oyama H; Taga S; Niwa T; Sun P; Ohtoyo M; Goto J
Steroids; 2008 Dec; 73(14):1485-99. PubMed ID: 18824188
[TBL] [Abstract][Full Text] [Related]
20. Isolation of equine herpesvirus-1 lacking glycoprotein C from a dead neonatal foal in Japan.
Kirisawa R; Hosoi Y; Yamaya R; Taniyama H; Okamoto M; Tsunoda N; Hagiwara K; Iwai H
Arch Virol; 2005 Dec; 150(12):2549-65. PubMed ID: 16012785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
